Calendar Genexine, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 03:30:00 30/04/2024 am IST			5-day change	1st Jan Change
7,510 ^KRW	+1.21%		+3.44%	-24.14%

2023	Genexine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Genexine, Inc. and PT Kalbe Genexine Biologics Receives the First Market Approval for Novel Long-Acting Erythropoietin, Efepoetin Alfa, from the Indonesian Food and Drug Authority	CI

9b0.Ysq88RTXFA83EU6FpYxdPL8bEhLSIBtUyfAdiBvy6hU.KpWPnHC8c151awj88OgQds18WGOnZGI5sbdX2jaam0ENvveWWrphOntZBw~0a4b54a6a21bcf474611a402d9f753cc

13/05/2024	Q1 2024 Earnings Release (Projected)
13/08/2024	Q2 2024 Earnings Release (Projected)
13/11/2024	Q3 2024 Earnings Release (Projected)
19/05/2025	Q1 2025 Earnings Release (Projected)

28/03/2024	Shareholders Meeting
13/03/2024	Q4 2023 Earnings Release
14/11/2023	Q3 2023 Earnings Release
05/06/2023 11:45 pm	American Society of Clinical Oncology Conference - Abstract No 6075
15/05/2023	Q1 2023 Earnings Release
20/03/2023	Q4 2022 Earnings Release
06/02/2023	BIO CEO & Investor Conference
09/01/2023	JP Morgan Healthcare Conference
14/11/2022	Q3 2022 Earnings Release
10/09/2022 12:05 pm	European Society for Medical Oncology Congress
16/08/2022	Interim 2022 Earnings Release
24/05/2022 04:30 pm	H.C. Wainwright Global Investment Conference
16/05/2022	Q1 2022 Earnings Release
17/08/2021	Interim 2021 Earnings Release
17/05/2021	Q1 2021 Earnings Release
19/03/2021	FY 2020 Earnings Release
30/03/2020	FY 2019 Earnings Release
14/11/2019	Q3 2019 Earnings Release
09/09/2019	Morgan Stanley Global Health Care Conference
14/05/2019	Q1 2019 Earnings Release

Fiscal Period	December	2019	2020	2021	2022	2023
Net sales Billions KRW	Released Forecast Spread	11,3 16,0 -29.39%	18,5 18,4 0.6%	0,00	0,47	3,87
EBITDA Billions KRW	Released Forecast Spread	-42,0 -33,8 -24.51%	-36,2 -31,1 -16.55%	0,00	0,00	0,00
EBIT Billions KRW	Released Forecast Spread	-44,5 -36,9 -20.53%	-39,2 -35,2 -11.31%	0,00	-10,6	-40,5
Earnings before Tax (EBT) Billions KRW	Released Forecast Spread	0,00 0,00 -	27,5 -43,4 163.45%	0,00	-16,9	-39,1
Net income Billions KRW	Released Forecast Spread	0,00 0,00 -	27,6 -43,4 163.52%	-47,7	-16,9	-39,1
EPS KRW	Released Forecast Spread	0,00 0,00 -	672 -1 402 147.89%	-1 473	-443	-967
Announcement Date		04/03/20	12/03/21	17/03/22	15/05/23	13/03/24

Fiscal Period	December	2023 Q3
Net sales Billions KRW	Released Forecast Spread	0,36
Announcement Date		15/11/23

06/05/2024	FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
06/05/2024	KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
06/05/2024	MERUS N.V.: Q1 2024 Earnings Release (Projected)
06/05/2024	VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	BIONTECH SE: Q1 2024 Earnings Release
06/05/2024 04:30 pm	BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 01:31 am	VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
07/05/2024	COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024	LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)

03/05/2024 01:31 am	ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
02/05/2024 08:30 pm	GENMAB A/S: Q1 2024 Earnings Release
02/05/2024 04:30 pm	AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 04:00 pm	SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 04:00 pm	REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 03:30 pm	AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
02/05/2024	ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
02/05/2024	DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
02/05/2024	GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024	KURA ONCOLOGY, INC.: Q1 2024 Earnings Release